Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J petitions FDA to require "similar" names for biosimilars, biologics
J&J petitions FDA to require "similar" names for biosimilars, biologics
J&J petitions FDA to require "similar" names for biosimilars, biologics
Submitted by
admin
on January 9, 2014 - 8:30am
Source:
Yahoo/Reuters
News Tags:
JNJ
FDA
biosimilars
Mylan
Novartis
Headline:
J&J petitions FDA to require "similar" names for biosimilars, biologics
Do Not Allow Advertisers to Use My Personal information
